TRIAL RESULTS

The majority of the research studies conducted at Clinvest are multi-center nation or world- wide studies involving hundreds to thousands of participants.

Expanding Access to Triptans: Assessing Clinical Outcome View

  • Comparing liberal vs. limited access to Maxalt® to evaluate the effect on headache management.
  • Conducted at Clinvest in 2008 with 21 participants

The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgia View

  • Evaluated a dual acting anti- depressant in the treatment of the symptoms of fibromyalgia
  • Conducted at Clinvest in 2008 with 11 participants

Predictors to Adherence to Triptans:Factors of Sustained vs Lapsed Users View

  • Compared the effectiveness and side effects of a triptan to non-triptan drugs for acute migraine among people current and former triptan users
  • Conducted at Clinvest in 2008 with 21 participants

Sumavel® DosePro® for Acute Migraine View

  • Needle-free delivery system for acute migraine treatment
  • 2 studies conducted at Clinvest in 2007 and 2009 with 20 participants

Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education
on Treatment Response View

  • Evaluated the effect of migraine education on the effectiveness of satisfaction with treatment
  • Conducted at Clinvest in 2007 with 20 participants

Combination Treatment for Menstrual Migraine and Dysmenorrhea Using Sumatriptan–Naproxen View

  • Evaluating Treximet® for the treatment of menstrual headaches
  • Conducted at Clinvest in 2006 with 20 participants

Botulinum Toxin Type A as Migraine Preventive View

  • Treatment with Botox for patients suffering from 15 or more headache days per month
  • Conducted at Clinvest in 2005-2006 with 28 participants

AEGIS View

  • Treatment with Axert ® at mild migraine pain
  • Conducted at Clinvest in 2004-2005 with 16 participants

MEWT: Migraine Early Warning Tool View

  • MEWT, developed by Clinvest Researchers, Dennis Reeves, PhD and Kathleen Farmer, PhD, was developed from ANAM, a battery of tests designed by military scientists to measure how efficiently the brain is working. ANAM has been used to evaluate troops for combat readiness.
  • The MEWT and ANAM have been used in 7 studies developed by Clinvest investigators and in cooperation with major pharmaceutical companies and the military.


 
Return to Clinvest Home Page